Healthcare Regulatory Alerts
CIHQ-ARS notifies its client organizations of any new or modified accreditation standard, or CMS COP for acute care hospitals. Alerts are also published when changes are made by CDC, OSHA, NIOSH, NFPA. Each alert summarizes the standard, regulation, recommendations, likely impact to members, and recommendations for compliance strategies. Whenever possible, alerts are limited to one-page in length so that they can be quickly read and disseminated.
New Regulatory Alert
Date: January 6, 2023
Subject: HHS Alerts Health Sector to New Ransomware Threat
Source: Other-AHA
Summary:
In an article on January 5, 2023, the American Hospital Association (AHA) stated that the Health and Human Services (HHS) issued a warning of a new ransomware threat affecting the health sector.
Discussion & Recommendations:
CIHQ Accredited Hospitals, ARS Members and Healthcare Accreditation Certified Professions: To view the discussion & recommendations portion of the alert, log in to your facilities account. All alerts are archived in the library for future access and reference.
Not a CIHQ Accredited Facility, ARS Member or hold HACP certification?
» Visit CIHQ.org to learn more, and to apply.
New Regulatory Alert
Date: January 12, 2023
Subject: HHS Extends COVID-19 Public Health Emergency Declaration
Source: Other-AHHS
Summary:
In a declaration dated January 11, 2023, Secretary of Health and Human Services Xavier Becerra extended the public health emergency due to the COVID-19 virus. The extension is effective for the next 90 days.
Discussion & Recommendations:
CIHQ Accredited Hospitals, ARS Members and Healthcare Accreditation Certified Professions: To view the discussion & recommendations portion of the alert, log in to your facilities account. All alerts are archived in the library for future access and reference.
Not a CIHQ Accredited Facility, ARS Member or hold HACP certification?
» Visit CIHQ.org to learn more, and to apply.
New Regulatory Alert
Date: January 19, 2023
Subject: CMS Announces Compliance Education Programs For Medicare Providers
Source: CMS
Summary:
On January 18, 2023, the ECRI released an executive brief for their Top 10 Health Technology Hazards for 2023.In a letter to State enforcement agencies (SA’) dated1/19/23, CMS announced that it has developed interactive training videos tailored for specific provider types. The intent of this initiative is to provide a resource for providers and suppliers to proactively address common compliance concerns and therefore increase the quality of care for patients.
Training vides can be accessed through the following link: https://qsep.cms.gov/ProvidersAndOthers/publictraining.aspx The videos can be located under the “Quality in Focus” tab.
Discussion & Recommendations:
CIHQ Accredited Hospitals, ARS Members and Healthcare Accreditation Certified Professions: To view the discussion & recommendations portion of the alert, log in to your facilities account. All alerts are archived in the library for future access and reference.
Not a CIHQ Accredited Facility, ARS Member or hold HACP certification?
» Visit CIHQ.org to learn more, and to apply.
New Regulatory Alert
Date: January 19, 2023
Subject: ECRI Releases their Top 10 Health Technology Hazards for 2023
Source: Other-ECRI
Summary:
On January 18, 2023, the ECRI released an executive brief for their Top 10 Health Technology Hazards for 2023.
Discussion & Recommendations:
CIHQ Accredited Hospitals, ARS Members and Healthcare Accreditation Certified Professions: To view the discussion & recommendations portion of the alert, log in to your facilities account. All alerts are archived in the library for future access and reference.
Not a CIHQ Accredited Facility, ARS Member or hold HACP certification?
» Visit CIHQ.org to learn more, and to apply.
New Regulatory Alert
Date: January 24, 2023
Subject: FDA Issues Guidance on Compounding Certain Ibuprofen Oral Suspension Products in Outsourcing Facilities
Source: Other-FDA
Summary:
On January 20, 2023, FDA announced the U.S. is experiencing a surge in COVID-19, respiratory syncytial virus (RSV), and influenza, which has led to an increased demand for pediatric fever-reducing medications. Hospitals and health systems have reported difficulties in obtaining certain FDA-approved ibuprofen oral suspension drug products.
Discussion & Recommendations:
CIHQ Accredited Hospitals, ARS Members and Healthcare Accreditation Certified Professions: To view the discussion & recommendations portion of the alert, log in to your facilities account. All alerts are archived in the library for future access and reference.
Not a CIHQ Accredited Facility, ARS Member or hold HACP certification?
» Visit CIHQ.org to learn more, and to apply.